MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension

Synthetic MicroRNA Cassette Dosing: Pharmacokinetics, Tissue Distribution and Bioactivity

(2012) Hongyan Wang et al.   MOLECULAR PHARMACEUTICS

Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension

(2011) Ryan S. Friese et al.   BLOOD PRESSURE

Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs

(2011) David M Garcia et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex

(2010) Andrea H. Gaede et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 Are Associated with Panic Disorder and Regulate Several Anxiety Candidate Genes and Related Pathways

(2010) Margarita Muiños-Gimeno et al.   BIOLOGICAL PSYCHIATRY

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

(2010) J Zhang et al.   BRITISH JOURNAL OF CANCER

An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples

(2010) Jianhua Xiong et al.   FEBS Journal

Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat

(2010) M.L. Jirout et al.   HUMAN MOLECULAR GENETICS

Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses

(2010) Sucheta M Vaingankar et al.   JOURNAL OF HYPERTENSION

miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics

(2010) Nadav Bar et al.   PLoS One

Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin

(2010) Víctor Sánchez-Margalet et al.   REGULATORY PEPTIDES

Chromogranin A: a novel susceptibility gene for essential hypertension

(2009) Bhavani S. Sahu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Peptide YY (PYY) Gene Polymorphisms in the 3′-Untranslated and Proximal Promoter Regions Regulate Cellular Gene Expression and PYY Secretion and Metabolic Syndrome Traitsin Vivo

(2009) Pei-an Betty Shih et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure

(2009) Yuqing Chen et al.   JOURNAL OF HYPERTENSION

Neuropeptide Y1Receptor NPY1R

(2009) Lei Wang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor   mRNA

(2009) D. P. Pandey et al.   MOLECULAR AND CELLULAR BIOLOGY

Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure

(2008) N. R. Mahapatra   CARDIOVASCULAR RESEARCH

Naturally Occurring Human Genetic Variation in the 3′-Untranslated Region of the Secretory Protein Chromogranin A Is Associated With Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion

(2008) Yuqing Chen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease

(2008) R. M. Salem et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure

(2008) Y. Chen et al.   KIDNEY INTERNATIONAL

SNP and haplotype mapping for genetic analysis in the rat

(2008) Kathrin Saar et al.   NATURE GENETICS